Candriam SCA’s Imago BioSciences, Inc. Common stock IMGO Stock Holding History

Candriam SCA’s Portfolio IMGO Stock Details IMGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-48,094	Closed	-$1.73M	–	954
2022 Q4	$1.73M	Buy	+48,094	New	+$1.2M	0.01%	608

Candriam SCA's IMGO Position: Q1 2023 in Review

Candriam SCA sold out of Imago BioSciences, Inc. Common stock (IMGO) in Q1 2023, closing a stake of 48,094 shares — an estimated $1.73M sold.

Candriam SCA first reported a position in IMGO in Q4 2022 and held it in 1 quarter. The position peaked at $1.73M in Q4 2022. 0 funds tracked by Wall St. Rank hold IMGO as of Q1 2023.

Candriam SCA reported no remaining Imago BioSciences, Inc. Common stock position as of Q1 2023 after selling out during the quarter.
Candriam SCA sold 48,094 Imago BioSciences, Inc. Common stock shares in Q1 2023, an estimated $1.73M.
Candriam SCA first reported a position in Imago BioSciences, Inc. Common stock in Q4 2022 and held it in 1 quarter.
Candriam SCA's Imago BioSciences, Inc. Common stock position peaked at $1.73M in Q4 2022.
0 funds tracked by Wall St. Rank held Imago BioSciences, Inc. Common stock as of Q1 2023.

Based on Candriam SCA's 13F filing for Q1 2023, filed 12 May 2023.